Evidence map›Paper›PMID 31766228›Full record

ReviewMarine drugs2019

Microalgal Carotenoids: A Review of Production, Current Markets, Regulations, and Future Direction.

Lucie Novoveská, Michael E Ross, Michele S Stanley, Rémi Pradelles, Virginie Wasiolek, Jean-François Sassi

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 2 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 2 syntheses or guidelines pooled it, 424 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Exploring the Potential ofMicroorganisms · 2025
    Review
  18. Article
  19. Review
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Lucie NovoveskáScottish Association for Marine Science (SAMS), Scottish Marine Institute, Oban PA37 1QA, UK.ORCID 0000-0002-5667-6769
Michael E RossScottish Association for Marine Science (SAMS), Scottish Marine Institute, Oban PA37 1QA, UK.
Michele S StanleyScottish Association for Marine Science (SAMS), Scottish Marine Institute, Oban PA37 1QA, UK.
Rémi PradellesMicrophyt, 713 Route de Mudaison, 34670 Baillargues, France.
Virginie WasiolekMicrophyt, 713 Route de Mudaison, 34670 Baillargues, France.
Jean-François SassiCommissariat à l'énergie atomique et aux énergies alternatives (CEA), Centre de Cadarache St Paul Lez, 13108 Durance, France.
Scottish Association For Marine Science · GBCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FR

Funding

European Union's Horizon 2020 R&I programme, ABACUS project Grant Agreement No 745668
6 · The paper itself

Abstract

Microalgae produce a variety of compounds that are beneficial to human and animal health. Among these compounds are carotenoids, which are microalgal pigments with unique antioxidant and coloring properties. The objective of this review is to evaluate the potential of using microalgae as a commercial feedstock for carotenoid production. While microalgae can produce some of the highest concentrations of carotenoids (especially astaxanthin) in living organisms, there are challenges associated with the mass production of microalgae and downstream processing of carotenoids. This review discusses the synthesis of carotenoids within microalgae, their physiological role, large-scale cultivation of microalgae, up- and down-stream processing, commercial applications, natural versus synthetic carotenoids, and opportunities and challenges facing the carotenoid markets. We emphasize legal aspects and regulatory challenges associated with the commercial production of microalgae-based carotenoids for food/feed, nutraceutical and cosmetic industry in Europe, the USA, the People's Republic of China, and Japan. This review provides tools and a broad overview of the regulatory processes of carotenoid production from microalgae and other novel feedstocks.

Indexed as

AnimalsAntioxidantsCarotenoidsColoring AgentsHumansMicroalgaeAntioxidantsCarotenoidsColoring Agentsantioxidantscarotenoidsfeedstocklegislationmass production of microalgaemicroalgaeregulations

Identifiers

PMID31766228
PMCPMC6891288
OpenAlexW2988271294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.